University of Surrey

Test tubes in the lab Research in the ATI Dance Research

The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines

Coley, HM, Shotton, CF, Kokkinos, MI and Thomas, H (2007) The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines GYNECOLOGIC ONCOLOGY, 105 (2). pp. 462-469.

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Coley, HMh.coley@surrey.ac.ukUNSPECIFIED
Shotton, CFUNSPECIFIEDUNSPECIFIED
Kokkinos, MIUNSPECIFIEDUNSPECIFIED
Thomas, HUNSPECIFIEDUNSPECIFIED
Date : 1 May 2007
Identification Number : 10.1016/j.ygyno.2007.01.004
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology, Obstetrics & Gynecology, OBSTETRICS & GYNECOLOGY, ONCOLOGY, uterine sarcoma, seliciclib, CYC202, roscovitine, CDK inhibition, cisplatin, combination therapy, apoptosis, GYNECOLOGIC-ONCOLOGY-GROUP, CYC202 R-ROSCOVITINE, SOFT-TISSUE SARCOMAS, NUCLEAR ACCUMULATION, CYCLIN D1, P53, EXPRESSION, DOCETAXEL, MITOMYCIN
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 08:57
Last Modified : 17 May 2017 14:38
URI: http://epubs.surrey.ac.uk/id/eprint/821584

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800